ALC-0315
CAS No. 2036272-55-4
ALC-0315( —— )
Catalog No. M37618 CAS No. 2036272-55-4
ALC-0315 is an ionizable amino lipid that has been used in combination with other lipids to form lipid nanoparticles. Lipid-Nanoparticles have been used in the research of mRNA COVID-19 vaccine
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 60 | Get Quote |
|
| 10MG | 82 | Get Quote |
|
| 25MG | 123 | Get Quote |
|
| 50MG | 177 | Get Quote |
|
| 100MG | 254 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameALC-0315
-
NoteResearch use only, not for human use.
-
Brief DescriptionALC-0315 is an ionizable amino lipid that has been used in combination with other lipids to form lipid nanoparticles. Lipid-Nanoparticles have been used in the research of mRNA COVID-19 vaccine
-
DescriptionALC-0315 is an ionisable aminolipid that is responsible for mRNA compaction and aids mRNA cellular delivery and its cytoplasmic release through suspected endosomal destabilization. ALC-0315 can be used to form lipid nanoparticle (LNP) delivery vehicles. Lipid-Nanoparticles have been used in the research of mRNA COVID-19 vaccine.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2036272-55-4
-
Formula Weight766.27
-
Molecular FormulaC48H95NO5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : 100 mg/mL (130.50 mM; Ultrasonic) DMSO : 50 mg/mL (65.25 mM; Ultrasonic )
-
SMILESCCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCO)CCCCCCOC(=O)C(CCCCCC)CCCCCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Moghimi SM. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines. Mol Ther. 2021;29(3):898-900.?
molnova catalog
related products
-
2-(2-Aminothiazole-4...
2-(2-Aminothiazole-4-yl)-2-methoxyiminoa is a compound.
-
Platelet-Derived Gro...
Platelet-Derived Growth Factor Receptor Substrate 2
-
N-(2,6-dioxopiperidi...
N-(2,6-dioxopiperidin-3-yl)-4-nitrophthalimide exhibit inhibition of CRBN.
Cart
sales@molnova.com